PRUNE expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.207600E-01
Normal-vs-Stage2
7.838800E-01
Normal-vs-Stage3
5.044400E-01
Normal-vs-Stage4
6.544200E-02
Stage1-vs-Stage2
1.361380E-01
Stage1-vs-Stage3
8.721700E-02
Stage1-vs-Stage4
8.716800E-01
Stage2-vs-Stage3
2.079600E-01
Stage2-vs-Stage4
2.673700E-02
Stage3-vs-Stage4
3.564200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.062800E-01
Normal-vs-AfricanAmerican
2.696600E-01
Normal-vs-Asian
6.722800E-01
Caucasian-vs-AfricanAmerican
2.845000E-01
Caucasian-vs-Asian
9.196000E-01
AfricanAmerican-vs-Asian
3.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.362800E-01
Normal-vs-Female
7.444000E-01
Male-vs-Female
4.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.382800E-01
Normal-vs-Age(41-60Yrs)
4.716800E-01
Normal-vs-Age(61-80Yrs)
8.075200E-01
Normal-vs-Age(81-100Yrs)
8.419400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.848400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.753620E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.184200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.261800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.986400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.008000E-01
Normal-vs-Daily Drinker
7.879000E-01
Normal-vs-Weekly Drinker
8.945200E-01
Normal-vs-Occasional Drinker
2.801000E-01
Normal-vs-Social Drinker
6.627600E-01
Non Drinker-vs-Daily Drinker
7.649000E-01
Non Drinker-vs-Weekly Drinker
6.275600E-01
Non Drinker-vs-Occasional Drinker
1.279550E-02
Non Drinker-vs-Social Drinker
2.490600E-01
Daily Drinker-vs-Weekly Drinker
4.830800E-01
Daily Drinker-vs-Occasional Drinker
8.997900E-03
Daily Drinker-vs-Social Drinker
1.885760E-01
Weekly Drinker-vs-Occasional Drinker
6.600100E-02
Weekly Drinker-vs-Social Drinker
5.889600E-01
Occasional Drinker-vs-Social Drinker
1.684230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.482300E-02
Normal-vs-Grade 2
2.098200E-03
Normal-vs-Grade 3
2.495500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.502000E-01
Grade 1-vs-Grade 3
9.250000E-01
Grade 1-vs-Grade 4
4.482300E-02
Grade 2-vs-Grade 3
9.515800E-01
Grade 2-vs-Grade 4
2.098200E-03
Grade 3-vs-Grade 4
2.495500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.738400E-01
Normal-vs-NonDiabetic
6.419400E-01
Diabetic-vs-NonDiabetic
1.314990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.459800E-01
Normal-vs-NoPancreatitis
7.360000E-01
Pancreatitis-vs-NoPancreatitis
9.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.331000E-01
Normal-vs-N1
8.249400E-01
N0-vs-N1
8.958300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.822200E-01
Normal-vs-TP53-NonMutant
3.053800E-01
TP53-Mutant-vs-TP53-NonMutant
1.523760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
